ORBIMED ADVISORS LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Loxo Oncology, Inc. ($LOXO).
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CCXI, ICPT, LOXO, RLYP, RPBIF, ROKA, SUPN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 56,490 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 5,931,402 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 80,715 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 8,475,069 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 38,021 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,992,203 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 116,981 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 12,238,019 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 12.00 | 3,616 | 43,392 | 30,378 | 26.8 K to 30.4 K (+13.51 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 12.00 | 379,717 | 4,556,604 | 3,190,051 | 2.8 M to 3.2 M (+13.51 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 5,116 | 0 | 26,762 | 21.6 K to 26.8 K (+23.63 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 537,264 | 0 | 2,810,334 | 2.3 M to 2.8 M (+23.64 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 7,563 | 0 | 21,646 | 14.1 K to 21.6 K (+53.70 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 794,178 | 0 | 2,273,070 | 1.5 M to 2.3 M (+53.70 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,443 | 0 | 14,083 | 10.6 K to 14.1 K (+32.36 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 361,612 | 0 | 1,478,892 | 1.1 M to 1.5 M (+32.37 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 10,596 | 0 | 10,640 | 44 to 10.6 K (+24,081.82 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,112,592 | 0 | 1,117,280 | 4.7 K to 1.1 M (+23,732.76 %) |
Sep 18 2014 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 25.07 | 49,000 | 1,228,430 | 8,857,551 | 8.9 M to 8.9 M (-0.55 %) |
Sep 18 2014 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.06 | 2,600 | 67,756 | 8,906,551 | 8.9 M to 8.9 M (-0.03 %) |
Sep 18 2014 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 25.45 | 42,400 | 1,079,080 | 8,909,151 | 9 M to 8.9 M (-0.47 %) |
Aug 19 2014 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.35 | 990,000 | 26,086,500 | 8,951,551 | 9.9 M to 9 M (-9.96 %) |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 337,973 | 0 | 0 | |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,562,499 | 0 | 0 | |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 275,385 | 3,580,005 | 2,175,857 | 1.9 M to 2.2 M (+14.49 %) |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 337,973 | 0 | 1,900,472 | 1.6 M to 1.9 M (+21.63 %) |
Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,562,499 | 0 | 1,562,499 | 0 to 1.6 M |
Nov 12 2013 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 3.58 | 151,632 | 542,843 | 151,632 | |
Nov 12 2013 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 3.58 | 2,408 | 8,621 | 2,408 | |
Nov 12 2013 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 3.58 | 254,122 | 909,757 | 254,122 | |
Nov 12 2013 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 2.45 | 303,265 | 742,999 | 1,818,677 | 1.5 M to 1.8 M (+20.01 %) |
Nov 12 2013 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 2.45 | 4,816 | 11,799 | 28,997 | 24.2 K to 29 K (+19.92 %) |
Nov 12 2013 | RPBIF | RESPONSE BIOMEDICA ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 2.45 | 508,244 | 1,245,198 | 3,047,927 | 2.5 M to 3 M (+20.01 %) |
Apr 15 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | M | 0.00 | 649 | 0 | 1,947 | |
Apr 15 2013 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Buy | M | 0.00 | 649 | 0 | 2,151,283 | 2.2 M to 2.2 M (+0.03 %) |
Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.58 | 41,100 | 311,361 | 817,000 | 858.1 K to 817 K (-4.79 %) |
Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.58 | 108,900 | 824,994 | 2,183,000 | 2.3 M to 2.2 M (-4.75 %) |
Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.52 | 41,483 | 312,027 | 858,100 | 899.6 K to 858.1 K (-4.61 %) |
Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.52 | 110,700 | 832,663 | 2,291,900 | 2.4 M to 2.3 M (-4.61 %) |
Dec 19 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.08 | 100,000 | 707,670 | 0 | 100 K to 0 (-100.00 %) |
Dec 19 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 6.85 | 197,815 | 1,354,617 | 100,000 | 297.8 K to 100 K (-66.42 %) |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 827,627 | 0 | 0 | |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,498,842 | 0 | 0 | |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 6,673,891 | 0 | 0 | |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 90,999 | 454,995 | 297,815 | 206.8 K to 297.8 K (+44.00 %) |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 274,873 | 1,374,365 | 899,583 | 624.7 K to 899.6 K (+44.00 %) |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 734,128 | 3,670,640 | 2,402,600 | 1.7 M to 2.4 M (+44.00 %) |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 206,816 | 0 | 206,816 | 0 to 206.8 K |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 624,710 | 0 | 624,710 | 0 to 624.7 K |
May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,668,472 | 0 | 1,668,472 | 0 to 1.7 M |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 242,674 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,574,345 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 514,354 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,888,423 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 10,706 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 78,928 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 908,509 | 0 | 908,509 | 0 to 908.5 K |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 2,201,388 | 0 | 2,201,388 | 0 to 2.2 M |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 44,817 | 0 | 44,817 | 0 to 44.8 K |
Page: 1